Tele-PROTECT Therapy for Depression and Elder Abuse
This study is looking at two virtual programs for people aged 60 and older who have experienced elder abuse and are also dealing with depression. One program is called Tele-PROTECT, which helps with depression by encouraging enjoyable activities and setting goals to reduce risk. The other program is Depression Education (DepEd), which provides education, support, and empathy. Both programs involve nine 45-minute virtual sessions. Researchers want to see if Tele-PROTECT is more effective than DepEd at reducing depression and helping participants feel more empowered to improve their safety. The study plans to enroll 140 participants.
- Study design
- This is a randomized study comparing two behavioral interventions, Tele-PROTECT and Depression Education, in 140 participants.
- What's involved
- You would participate in nine 45-minute virtual sessions for either Tele-PROTECT or Depression Education. Your depression levels will be assessed at the start, week three, week six, and week nine of treatment.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your depression levels will be monitored through week nine of treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation
At a glance
Conditions
NCT06039930
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Weill Cornell Medicine
New York, New Yorkstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Jo Anne Sirey, Ph.D · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Montgomery Asberg Depression Rating Scale (MADRS)Assessed at baseline and week three of treatment
The Montgomery Asberg Depression Rating Scale (MADRS) is a 10-item scale that assesses depression severity. Scores range from 0 to 60, with a score of 0 indicating no depressive symptoms present and a score of 60 indicating severe depression. Scores will be used to assess depression severity outcome and evaluate the impact of interventions in line with the Effectiveness Aim.
- Montgomery Asberg Depression Rating Scale (MADRS)Assessed baseline and week six of treatment
The Montgomery Asberg Depression Rating Scale (MADRS) is a 10-item scale that assesses depression severity. Scores range from 0 to 60, with a score of 0 indicating no depressive symptoms present and a score of 60 indicating severe depression. Scores will be used to assess depression severity outcome and evaluate the impact of interventions in line with the Effectiveness Aim.
- Montgomery Asberg Depression Rating Scale (MADRS)Assessed baseline and week nine of treatment
The Montgomery Asberg Depression Rating Scale (MADRS) is a 10-item scale that assesses depression severity. Scores range from 0 to 60, with a score of 0 indicating no depressive symptoms present and a score of 60 indicating severe depression. Scores will be used to assess depression severity outcome and evaluate the impact of interventions in line with the Effectiveness Aim.
- Montgomery Asberg Depression Rating Scale (MADRS)Assessed baseline and 3 weeks after treatment end, approximately 12 weeks from enrollment
The Montgomery Asberg Depression Rating Scale (MADRS) is a 10-item scale that assesses depression severity. Scores range from 0 to 60, with a score of 0 indicating no depressive symptoms present and a score of 60 indicating severe depression. Scores will be used to assess depression severity outcome and evaluate the impact of interventions in line with the Effectiveness Aim.
- Measure Of Victim Empowerment Related to Safety (MOVERS) ScaleAssessed at baseline and week three of treatment
The MOVERS a 13-item scale assesses the presence of a set of safety-related goals, the ability to accomplish them, and victims' sense that others can and will assist them as needed. Scores range from 13 to 65 with higher scores indicating a greater degree of empowerment related to safety. The MOVERS serves to measure the Abuse Impact Aim.
- Measure Of Victim Empowerment Related to Safety (MOVERS) ScaleAssessed at baseline and week six of treatment
The MOVERS a 13-item scale assesses the presence of a set of safety-related goals, the ability to accomplish them, and victims' sense that others can and will assist them as needed. Scores range from 13 to 65 with higher scores indicating a greater degree of empowerment related to safety. The MOVERS serves to measure the Abuse Impact Aim.
- Measure Of Victim Empowerment Related to Safety (MOVERS) ScaleAssessed at baseline and week nine of treatment
The MOVERS a 13-item scale assesses the presence of a set of safety-related goals, the ability to accomplish them, and victims' sense that others can and will assist them as needed. Scores range from 13 to 65 with higher scores indicating a greater degree of empowerment related to safety. The MOVERS serves to measure the Abuse Impact Aim.
- Measure Of Victim Empowerment Related to Safety (MOVERS) ScaleAssessed baseline and 3 weeks after treatment end, approximately 12 weeks from enrollment
The MOVERS a 13-item scale assesses the presence of a set of safety-related goals, the ability to accomplish them, and victims' sense that others can and will assist them as needed. Scores range from 13 to 65 with higher scores indicating a greater degree of empowerment related to safety. The MOVERS serves to measure the Abuse Impact Aim.